Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker

Sahm, V., Maurer, C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022). Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget, 13(1), 347–359. https://doi.org/10.18632/oncotarget.28198
Authors:
Vincenz Sahm
H. Carlo Maurer
Theresa Baumeister
Akanksha Anand
Julia Strangmann
Roland M. Schmid
Timothy C. Wang
Michael Quante
Affiliated Authors:
Timothy C. Wang
Columbia Affiliation:
Subjects:
Barrett Esophagus (MeSH)
Esophageal Neoplasms (MeSH)
Preoperative Chemoradiotherapy for Esophageal Cancer (OpenAlex Topic)
Malignant Pleural Mesothelioma Research (OpenAlex Topic)
Macrophage Activation and Polarization (OpenAlex Topic)
Author Keywords:
barrett's esophagus
tert/terc
esophageal cancer
risk factor
telomere shortening
elink
Publication Type:
Article
Unique ID:
10.18632/oncotarget.28198
PMID:
35178191
DOI:
10.18632/oncotarget.28198
Journal:
Oncotarget
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record

Record Created: